financetom
Business
financetom
/
Business
/
Las Vegas Sands Insider Sold Shares Worth $6,499,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Las Vegas Sands Insider Sold Shares Worth $6,499,000, According to a Recent SEC Filing
Nov 10, 2025 2:32 PM

05:09 PM EST, 11/10/2025 (MT Newswires) -- D. Zachary Hudson, Executive Vice President and Global General Counsel, on November 07, 2025, sold 100,000 shares in Las Vegas Sands ( LVS ) for $6,499,000. Following the Form 4 filing with the SEC, Hudson has control over a total of 13,735 common shares of the company, with 13,735 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1300514/000178718025000003/xslF345X05/wk-form4_1762812166.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Neuronetics Appoints Steven Pfanstiel as CFO
Neuronetics Appoints Steven Pfanstiel as CFO
Jul 15, 2025
07:49 AM EDT, 07/15/2025 (MT Newswires) -- Neuronetics ( STIM ) said Tuesday that it has named Steven Pfanstiel to replace Steve Furlong as its new Chief Financial Officer, starting July 15. The company said Furlong will stay as senior advisor to the CEO until the end of March 2026 to ensure a smooth transition, it added. Before the appointment,...
State Street's Q2 Earnings, Revenue Increase
State Street's Q2 Earnings, Revenue Increase
Jul 15, 2025
07:53 AM EDT, 07/15/2025 (MT Newswires) -- State Street (STT) reported Q2 earnings Tuesday of $2.17 per diluted share, up from $2.15 a year earlier. Analysts polled by FactSet expected $2.31. Revenue for the quarter ended June 30 was $3.45 billion, compared with $3.19 billion a year earlier. Analysts polled by FactSet expected $3.35 billion. ...
Iovance Biotherapeutics Names Corleen Roche as Chief Financial Officer
Iovance Biotherapeutics Names Corleen Roche as Chief Financial Officer
Jul 15, 2025
07:49 AM EDT, 07/15/2025 (MT Newswires) -- Iovance Biotherapeutics ( IOVA ) said Tuesday it has appointed Corleen Roche as chief financial officer, effective Aug. 6. Roche most recently served as CFO of CG Oncology (CGON). Iovance shares were down 6% in recent premarket activity. ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved